These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2417678)

  • 1. Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?
    Patel JK; Nemoto T; Vezeridis M; Petrelli N; Suh O; Dao TL
    Cancer; 1986 Feb; 57(3):567-70. PubMed ID: 2417678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of current palliative treatment on the survival of patients with breast cancer.
    Devitt JE; Advent DA
    Can J Surg; 1977 Jan; 20(1):46-50. PubMed ID: 64291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic breast cancer.
    Vogel CL
    Semin Oncol Nurs; 1991 Aug; 7(3):194-9. PubMed ID: 1718024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in primary inoperable breast cancer patients.
    Dimitrakakis C; Keramopoulos A
    Eur J Gynaecol Oncol; 2004; 25(3):367-72. PubMed ID: 15171321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with metastatic breast cancer diagnosed between 1955 and 1980.
    Debonis D; Terz JJ; Eldar S; Hill LR
    J Surg Oncol; 1991 Nov; 48(3):158-63. PubMed ID: 1943110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy in metastasized breast carcinoma].
    Bontenbal M; de Wit R; Klijn JG; Seynaeve C
    Ned Tijdschr Geneeskd; 1998 Jul; 142(30):1709-13. PubMed ID: 9763866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.
    Rier HN; Jager A; Sleijfer S; van Rosmalen J; Kock MCJM; Levin MD
    Breast; 2017 Feb; 31():9-15. PubMed ID: 27810702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local therapy in metastatic breast cancer is associated with improved survival.
    Sofi AA; Mohamed I; Koumaya M; Kamaluddin Z
    Am J Ther; 2013; 20(5):487-92. PubMed ID: 21822115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea.
    Kim HK; Lee SH; Kim YJ; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Ahn JS; Im YH; Yu JH; Park YH
    BMC Cancer; 2019 Jan; 19(1):84. PubMed ID: 30654765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic oophorectomy in disseminated carcinoma of the breast.
    Puga FJ; Welch JS; Bisel HF
    Arch Surg; 1976 Aug; 111(8):877-80. PubMed ID: 60095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-related surgery in patients with distant metastatic breast cancer.
    Amann E; Huang DJ; Weber WP; Eppenberger-Castori S; Schmid SM; Hess TH; Güth U
    Eur J Surg Oncol; 2013 Nov; 39(11):1192-8. PubMed ID: 24029666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center.
    O'Connor TL; Ngamphaiboon N; Groman A; Luczkiewicz DL; Kuszczak SM; Grant PC; Kerr CW
    J Palliat Med; 2015 Jan; 18(1):50-5. PubMed ID: 25353618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliation and breast cancer.
    Yip CH
    J Surg Oncol; 2017 Apr; 115(5):538-543. PubMed ID: 28097656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
    Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
    J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of surgical excision on survival of patients with stage IV breast cancer.
    Leung AM; Vu HN; Nguyen KA; Thacker LR; Bear HD
    J Surg Res; 2010 Jun; 161(1):83-8. PubMed ID: 19375721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of therapy in advanced breast cancer.
    Ingle JN
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):743-63. PubMed ID: 2481669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer.
    Morrogh M; Miner TJ; Park A; Jenckes A; Gonen M; Seidman A; Morrow M; Jaques DP; King TA
    Cancer; 2010 Jul; 116(14):3338-47. PubMed ID: 20564060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
    Shen T; Gao C; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.